ZKZeynep Asli Oskovi Kaplan

Zeynep Asli Oskovi Kaplan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zeynep Asli Oskovi Kaplan has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neonatal antibodies are detected in cord blood after vaccination of pregnant woman with the inactivated SARS-CoV-2 vaccine: A case report

    by Zeynep Asli Oskovi̇ Kaplan, A. Seval Özgü-Erdi̇nÇ, Gul Nihal Buyuk, Eda Üreyen Özdemi̇r, Cüneyt Tayman, Bedia Di̇nÇ, Özlem Moraloğlu Teki̇n

    Studies evaluating the safety and efficacy of currently available vaccines for SARS-CoV-2 do not include pregnant women and newborns. Safety data for vaccinating pregnant women with the COVID-19 vaccine is urgently needed since the vaccine is the only way to protect the vulnerable population. The 33 years-old pregnant women, a healthcare worker as an obstetrician and gynecologist, was vaccinated with inactivated SARS-CoV-2 vaccine with two doses within 28 days apart as the recommended protocol, on her 29th week and 33rd week of pregnancy. The rest of the pregnancy was uneventful and she gave birth on the 38th week to a healthy infant. The infant was a healthy boy upon first evaluation. Maternal blood was sampled immediately after birth, cord blood was obtained from a neonate for the immunoglobulin testing method. COVID-19 IgG and IgM antibodies for spike antigen was reported maternal as 2.04 (reactive) and the cord blood as 1.36 (reactive in a low titration). In this case we report an infant with SARS-CoV-2 IgG and IgM antibodies detectable in cord blood after maternal vaccination with inactivated vaccine.

  • Open Access

    Leiyomiyomu olan kadınlarda dolaşımdaki obestatin düzeyleri

    by Zeynep Asli Oskovi̇ Kaplan, Naci Tataç

    Objective: Uterine leiomyomas are the most common benign tumors of reproductive age women with symptoms of bleeding, pain, pressure and consequences on reproduction. Obestatin is a recently discovered secreted peptide encoded by the preproghrelin gene. The role of obestatin in the regulation of metabolism is still under debate. In this article, we investigate the use of biomarker in patients with uterine leiomyoma. Our goal is to study the obestatin as a biomarker for the diagnosis and monitoring of uterine leiomyoma. Methods: This cross-sectional observational study was conducted between January 2015–June 2015 in outpatient gynecology clinic of Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara. A total of 82 women were recruited as 48 with uterine leiomyoma and 34 healthy controls.The obestatin levels were reviewed prospectively. Results: The obestatin levels of study group was lower than the control group (1.91±2.64 pg/mL vs. 3.58±4.81 pg/mL, p ꓿.009). The obestatin levels without normal distribution, Mann–Whitney U-test was performed for two independent groups. Conclusion: Increased obestatin characterized obesity in women, supporting the hypothesis that the imbalance of obestatin may have a role in the pathophysiology of leiomyoma due to obesity. On the other hand, some relevant differences between our data on circulating blood levels of obestatin in normal-weight women who had leiomyoma subjects and those reported in the few studies published so far imply that further extensive research in this new area is needed.

  • Comparison of the Kisspeptin levels in early onset preeclampsia and late-onset preeclampsia

    by Mujde Can Ibanoglu, Z. Asli Oskovi-Kaplan, A. Seval Ozgu-Erdinc, Ozgur Kara, Dilek Sahin

    Objective Maternal Kisspeptin plays role in cell migration which is responsible for trophoblast invasion. We aimed to investigate the role of Kisspeptin as an invasion marker in the early-onset and late-onset preeclampsia cases. Study design In this case–control study, 125 patients were included: 20 patients with early-onset preeclampsia and 20 gestational-age-matched healthy controls; 45 patients with late-onset preeclampsia and 40 gestational-age-matched controls). Maternal plasma Kisspeptin concentration was measured and compared in groups regarding the presence of early-onset and late-onset preeclampsia. Results In the late-onset PE group, significantly higher maternal plasma Kisspeptin values were observed compared with the control group at > 34 weeks of gestation (68.7 ± 93.4 pg/ml vs 68.5 ± 57.9 pg/ml; p = 0.004). Before the 34th week of gestation, plasma Kisspeptin levels did not show a significant difference when patients with early-onset PE and gestational-age matched controls were compared (66.8 ± 87.9 pg/ml vs 48.5 ± 91.3 pg/ml; p = 0.56). Conclusion Plasma Kisspeptin levels were significantly higher in women with late-onset preeclampsia, while no significant difference was observed in early-onset preeclampsia when compared with healthy gestational age-matched controls. The role of Kisspeptin proteins is still not clearly defined in the pathogenesis of preeclampsia.


  • Open Access

    Oxytocin Versus Dinoprostone For Labor Induction in Multiparous Women with Unfavorable Cervix

    by Gul Nihal Buyuk, Umit Yasemin Sert, Zeynep Asli Oskovi Kaplan, Serkan Kahyaoglu

    OBJECTIVE: Dinoprostone is a drug of choice in our daily practice for the induction of labor. The aim of our study; to compare the use of oxytocin with dinoprostone (PGE2- Propess©) used in term multiparous pregnant women to ripen the cervix. STUDY DESIGN: A total of 507 patients were included in the study. Group A, consisted of 262 women with term multiparous pregnancy Bishop score ≤6 underwent induction of labor with a vaginal insert containing 10-mg timed-release dinoprostone (Propess© -prostaglandin E2). Group B, consisted of 245 cases of pregnancy with Bishop score ≤6 underwent induction of labor with iv oxytocin and was matched for the patient's age and parity. The following data were recorded: age, gestational age, body mass index, the time from the drug administration to the vaginal labor, delivery mode, indications of induction, cesarean indication, birth weight, Apgar score, and need of neonatal intensive care unit. RESULTS: The primary outcome of the in group B interval from induction to vaginal delivery was similar between the two groups. In group A, 41 patients and in group B, 23 patients had a cesarean section. Cesarean section rate was lower in the oxytocin group (cesarean rate 15.6% versus 9.3%, pCONCLUSION: It appears; Dinoprostone ovule increases the cesarean rate in terms, multiparous cases with inappropriate cervical score and does not shorten the duration of delivery. Therefore, the use of oxytocin for cervical ripening in multiparous women may be a more appropriate option.


  • Do fetuin-A/apha2-Heremans Schmid-glycoprotein levels have an association with recurrent pregnancy loss?

    by A. Seval Ozgu-Erdinc, Z. Asli Oskovi-Kaplan, Kudret Erkenekli, Nafiye Yilmaz, Yaprak Engin-Ustun, Aykan Yücel, Dilek Uygur

    Fetuin-A is a hepatokine which is previously found related to fertility and pregnancy outcomes. We aimed to investigate if recurrent pregnancy loss (RPL) is associated with increased fetuin-A level...


  • Open Access

    Is There A Relationship Between The Umbilical Cord Coiling Index And Oxidative Stress Markers And SGA Fetuses?

    by Gul Nihal Buyuk, Zeynep Asli Oskovi Kaplan, Umit Yasemin Sert, Inci Halilzade, Salim Neselioglu, Ozcan Erel, Huseyin Levent Keskin

    Objective: We aimed to investigate the relationship between umblical coiling index and thiol/disulfide balance in SGA newborns to compare with AGA newborns. Material and Methods: Fetal umbilical cord serum samples were collected during labour and the thiol/disulfide homeostasis was measured. After birth, umbilical cords were collected and cord parameters were examined including, length, number of coils, umbilical cord index. Results: Significant decrease in native thiol, total thiol, and a significant increase in disulfide, disulfide/native thiol ratio and disulfide/total thiol ratios were observed in the study group while native thiol/total thiol ratio levels of the two groups did not reach to a statistical significance. Conclusion: The results of this study showed that SGA babies had altered thiol homeostasis in favor of oxidative stress.


  • Open Access

    Technique to reduce blood loss during open abdominal myomectomy: transverse or vertical incision?

    by Ozlem Uzunlar, Mujde Can Ibanoglu, Asli Kaplan

    To determine if there is a difference between uterine incision techniques (vertical vs. transversal) in terms of clinical results. All women with leiomyomas who underwent open abdominal myomectomy (n=61) between March and August 2016 at the Gynecology and Obstetrics Clinic at the Women's Health Research and Training Hospital Zekai Tahir Burak were included, and the clinical results were included and prospectively reviewed. The estimated blood loss during myomectomy increased in the transversal group compared with the vertical group (809.33±483.34 versus 405.32±180.95 mL, p<0.001). The average operation duration was 60 min, and the patients got discharged on the second day after surgery. No intergroup statistical differences were observed in the surgical procedure. Surgeons should give preference to the most viable incision depending on the size and location of the leiomyoma.


  • Copper and levonorgestrel containing intrauterine devices: comparison of their effect on oxidative stress markers

    by Gul Nihal Buyuk, Z. Asli Oskovi-Kaplan, Hatice Kansu-Celik, Salim Neselioglu, Ozcan Erel, Yaprak Engin-Ustun

    We aimed to evaluate the oxidative stress by measuring the thiol-disulfide balance in women who use either T380A or LNG-IUD as a contraceptive method. Material and method: The study included two groups; 30 women with LNG-IUD and 30 women with copper-IUD. Thiol-disulfide homeostasis as a marker of oxidative stress was analyzed before the IUD insertion and on the 6th month after insertion. Results: The LNG-IUD group had similar native thiol levels with Cu-IUD (293.1 ± 43.5 µmol/l vs. 290.4 ± 42.4 µmol/l respectively, p = 819). In the copper-IUD group total thiol levels were higher than LNG-IUD group (345.5 ± 58.2 µmol/l vs. 319.5 ± 52.4 µmol/l, p = .031). A significant increase was observed after 6 months in LNG-IUD patients in terms of disulfide/native thiol (7.9 ± 4.4% vs. 11.2 ± 2.6%, p = .006), disulfide/total thiol (6.2 ± 1.8% vs. 8.7 ± 1.9%, p = .004) and Native thiol/total thiol (87.1 ± 12.1% vs. 82.3 ± 8.2%, p = .004) levels. After 6 months in copper-IUD patients, disulfide (22.3 ± 7.3 µmol/l vs. 27.5 ± 6.9 µmol/l respectively, p = .006), disulfide/native thiol (7.7 ± 3.8% vs. 9.8 ± 2.4% respectively, p = .007), disulfide/total thiol (6.4 ± 2.03% vs. 8.2 ± 1.8% respectively, p = .007) and native thiol/total thiol (86.3 ± 9.4% vs. 83.8 ± 10.6% respectively, p = .007) levels were increased. Conclusion: An increase in oxidative stress markers were observed in both groups. Studies evaluating the long term subclinical risks of IUD’s are needed to understand the outcomes of the increased oxidative stress.


  • Identifying the risk factors and incidence of Asherman Syndrome in women with post‐abortion uterine curettage

    by Fahrünnisa Sevinç, Z. Asli Oskovi‐Kaplan, Şevki Çelen, Deniz Ozturk Atan, Hasan Onur Topçu

    Aim: To evaluate the risk factors and incidence of Asherman Syndrome in women with post‐abortion uterine evacuation and curettage.Methods: A total of 2546 patients who had surgical abortion (uterine evacuation and curettage) before the 20th gestational week with indications of missed abortion, anembryonic pregnancy, incomplete abortion, and elective curettage in a tertiary antenatal care center were recruited. The patients were called and surveyed for their symptoms; including infertility, oligo‐amenorrhea and recurrent pregnancy loss, preterm birth and intrauterine growth retardation and abnormal placentation as criteria of Asherman Syndrome. Diagnostic (office) hysteroscopy was performed for 177 who had one of those complaints.Results: The incidence of Asherman Syndrome was 1.6% (n = 43/2546). History of ≥3 abortions was the main factor that increased the risk of Asherman Syndrome for by 4.6 times. Use of vacuum aspiration or sharp curettage, premedication for cervical priming, and having a pregnancy >10th gestational weeks were not risk factors for Asherman Syndrome.Conclusion: When the diagnosis was based on presence of symptoms who underwent uterine instrumentation, the incidence of Asherman Syndrome was found to be 1.6%. Repeated abortions were the main risk factor for Asherman Syndrome and avoiding from repeated uterine instrumentations may have a role in prevention.